Attruby treats transthyretin amyloid cardiopathy (ATTR-CM), a rare but life-threatening heart condition. Analysts expect the drug to attain blockbuster status by 2030. As of February 17 ...

Neuropathic pain (NPP) is caused by damage to the somatosensory nervous system. Its prominent symptoms are spontaneous pain, hyperalgesia and abnormal pain. This pain is long-lasting and unbearable, ...

A case-study approach is used to show that screening approved, and frequently off-patent, drugs efficiently yields candidate medications suitable for clinical trials. The first two cases highlight ...

Unrecognized or silent myocardial infarction (MI) detected on an ECG is associated with first‐ever stroke, but the impact on stroke recurrence is unknown. We aimed to determine the association of ...